본문으로 건너뛰기
← 뒤로

Sex-based immune differences influence tumor progression in head and neck squamous cell carcinoma.

2/5 보강
Oral oncology 📖 저널 OA 16.3% 2021: 2/13 OA 2022: 2/23 OA 2023: 2/10 OA 2024: 5/23 OA 2025: 7/36 OA 2026: 7/39 OA 2021~2026 2026 Vol.176() p. 107929 OA Sex and Gender in Healthcare
TL;DR It is demonstrated that enhanced effector T cell function coupled with reduced immunosuppression underlies improved tumor control in females and underscores the importance of integrating sex as a biological variable in immuno-oncology.
Retraction 확인
출처
PubMed DOI PMC OpenAlex Semantic 마지막 보강 2026-04-28
OpenAlex 토픽 · Sex and Gender in Healthcare Cancer Immunotherapy and Biomarkers Single-cell and spatial transcriptomics

Jagadeesha S, Lamenza F, Upadhaya P, Chung C, Webb A, Nyati K

📝 환자 설명용 한 줄

It is demonstrated that enhanced effector T cell function coupled with reduced immunosuppression underlies improved tumor control in females and underscores the importance of integrating sex as a biol

이 논문을 인용하기

↓ .bib ↓ .ris
APA Sushmitha Jagadeesha, Felipe F. Lamenza, et al. (2026). Sex-based immune differences influence tumor progression in head and neck squamous cell carcinoma.. Oral oncology, 176, 107929. https://doi.org/10.1016/j.oraloncology.2026.107929
MLA Sushmitha Jagadeesha, et al.. "Sex-based immune differences influence tumor progression in head and neck squamous cell carcinoma.." Oral oncology, vol. 176, 2026, pp. 107929.
PMID 41818928 ↗

Abstract

Head and neck squamous cell carcinoma (HNSCC) presents with higher incidence and poorer prognosis in males compared to females, yet the mechanisms underlying this sex disparity remains unclear. We investigated whether sex-specific immune responses contribute to differential tumor control using syngeneic and oral carcinogen-induced HNSCC mouse models., Female mice exhibited significantly reduced tumor burden, delayed progression and decreased metastatic potential compared to males. Immune profiling revealed a more robust antitumor immune landscape in females, characterized by heightened effector T cell activation, increased production of pro-inflammatory cytokines (IFN-γ, TNF-α), reduced expression of T cell exhaustion markers (PD-1, TIGIT), and a lower frequency of immunosuppressive myeloid-derived suppressor cells. Importantly, CD8 T cell depletion in females abrogated the resistance to HNSCC in females, establishing CD8 T cells as key mediators of sex-dependent antitumor immunity. Collectively, these findings demonstrate that enhanced effector T cell function coupled with reduced immunosuppression underlies improved tumor control in females and underscores the importance of integrating sex as a biological variable in immuno-oncology.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기